Search

Search Constraints

You searched for: Author/Creator Zheng, Lianqing

Search Results

2. Bioavailability of acalabrutinib suspension delivered via nasogastric tube in the presence or absence of a proton pump inhibitor in healthy subjects. Issue 10 (25th May 2022)

3. Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton‐Pump Inhibitors. Issue 11 (27th August 2022)

6. Lipid changes after leaf wounding in Arabidopsis thaliana: expanded lipidomic data form the basis for lipid co‐occurrence analysis. (3rd October 2014)

7. Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2. Issue 2 (16th October 2020)

8. Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2. Issue 2 (16th October 2020)

9. Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2. Issue 2 (16th October 2020)

10. Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2. Issue 2 (16th October 2020)